Synchronous Endometrial Cancer Detected on 68 Ga-DOTATATE PET/CT

Clin Nucl Med. 2024 Jan 1;49(1):96-97. doi: 10.1097/RLU.0000000000004947. Epub 2023 Oct 25.

Abstract

A 50-year-old woman with history of metastatic neuroendocrine tumor underwent a follow-up PET/CT with 68 Ga-DOTATATE. An enlarged uterus with diffuse increased uptake warranted further investigation with an MRI that showed mass-like thickening of the endometrium, T2 hyperintensity, lobulated contour, and invasion of more than 50% of the myometrium. Biopsy revealed endometrial carcinoma with mucinous features. Mild to moderate uptake of the 68 Ga-DOTATATE by the uterus can be a normal physiological finding; however, it should prompt further investigation, particularly in a postmenopausal woman with concerning imaging or clinical findings.

Publication types

  • Case Reports

MeSH terms

  • Endometrial Neoplasms* / diagnostic imaging
  • Female
  • Humans
  • Middle Aged
  • Neuroendocrine Tumors* / diagnostic imaging
  • Organometallic Compounds*
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radionuclide Imaging

Substances

  • copper dotatate CU-64
  • Organometallic Compounds